Comparison of HER2 mRNA Amplification with Immunohistochemistry in Human Breast Cancer Using Laser Assisted Microdissection Technique

Acta Histochemica et Cytochemica

Volumn 37, Issue 2, 2004, Pages 73-79

  Nakanishi, Yoko ^a   Mizutani, Gou ^a   Sano, Makoto ^a   Oinuma, Toshinori ^a,b   Nemoto, Norimichi ^a,b  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIHON UNIVERSITY   (Japan)

Author keywords

Breast cancer; HER2; Immunohistochemistory; Laser microdissection; RT PCR

Indexed keywords

ACETONE; BIOTIN; CARBON DIOXIDE; COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GUANIDIUM THIOCYANATE; HEXANE; MESSENGER RNA; METHANOL; STREPTAVIDIN; THIOCYANIC ACID DERIVATIVE; TOLONIUM CHLORIDE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; BREAST CANCER; CANCER TISSUE; CHEMICAL LABELING; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA TRANSCRIPTION; EVALUATION; FLUORESCENCE; FROZEN SECTION; GENE AMPLIFICATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFORMED CONSENT; INSTRUMENT; LASER MICRODISSECTION; MEMBRANE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; RNA EXTRACTION; SCORING SYSTEM; STANDARDIZATION; THICKNESS; TISSUE SECTION; VALIDATION PROCESS;

EID: 1842633243     PISSN: 00445991     EISSN: None     Source Type: Journal    
DOI: 10.1267/ahc.37.73     Document Type: Article

References (20)

1. Buehler, H., Bangemann, N., Evers, K., Becker, C. and Schaller, G. (2000) Effective HER-2/neu diagnosis in breast cancer by a combination of immunohistochemistry and FISH. Proceedings of ASCO. 19; 76a.
2. Cooke, T., Reeves, J., Lanigan, A. and Stanton, P. (2001) HER2 as a prognostic and predictive marker for breast cancer. Ann. Oncol. 12 (Suppl. 1); S23-S28.
3. Emmert-Buck, M. R., Bonner, R. F., Smith, P. D., Chuaqui, R. F., Zhuang, Z., Goldstein, S. R., Weiss, R. A. and Liotta, L. A. (1996) Laser capture microdissection. Science 274; 998-1001.
4. Glockner, S., Lehmann, U., Wilke, N., Kleeberger, W., Langer, F. and Kreipe, H. (2001) Amplification of growth regulatory genes in intraductal breast cancer is associated with higher nuclear grade but not with the progression to invasiveness. Lab. Invest. 81; 565-571.
5. Hung, M.-C. and Lau, Y.-K. (1999) Basic science of HER-2/neu: a review. Semin. Oncol. 26; 51-59.
6. Hynes, N. E. and Stem, D. F. (1994) The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim. Biophys. Acta 1198; 165-184.
7. King, C. R., Swain, S. M., Porter, L., Steinberg, S. M., Lippman, M. E. and Gelmann, E. P. (1989) Heterogeneous expression of erbB-2 messenger RNA in human breast cancer. Cancer Res. 49; 4185-4191.
8. Lehmann, U., Glockner, S., Kleeberger, W., von Wasielewski, H. F. and Kreipe, H. (2000) Detection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reaction. Am. J. Pathol. 156; 1855-1864.
9. Luzzi, V., Holtschlag, V. and Watson, M. A. (2001) Expression profiling of ductal carcinoma in situ by laser capture microdissection and high-density oligonucleotide arrays. Am. J Pathol. 158; 2005-2010.
10. Pauletti, G., Godolphin, W., Press, M. F. and Slamon, D. J. (1996) Detection and quantification of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene 13; 63-72.
11. Rekhter, M. D. and Chen, J. (2001) Molecular analysis of complex tissues is facilitated by laser capture microdissection: critical role of upstream tissue processing. Cell Biochem. Biophys. 35; 103-113.
12. Roche, P. C. and Ingle, J. N. (1999) Increased HER2 with U.S. Food and Drug Administration-approved antibody. J. Clin. Oncol. 17; 434.
13. Schaller, G., Evers, K., Papadopoulos, S., Ebert, A. and Buhler, H. (2001) Current use of HER2 tests. Ann. Oncol. 12 (Suppl. 1); S97-S100.
14. Shak, S. (1999) Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer. Semin. Oncol. 26; 71-77.
15. Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A. and Press, M. F. (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244; 707-712.
16. Sliwkowski, M. X., Lofgren, J. A., Lewis, G. D., Hotaling, T. E., Fendly, B. M. and Fox, J. A. (1999) Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin). Semin. Oncol. 26; 60-70.
17. Specht, K., Richter, T., Muller, U., Walch, A., Werner, M. and Hofler, H. (2001) Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue. Am. J. Pathol. 158; 419-429.
18. Thor, A. (2001) HER2 - a discussion of testing approaches in the USA. Ann. Oncol. 12 (Suppl. 1); S101-S107.
19. Umemura, S., Sekido, Y., Itoh, H. and Osamura, R. Y. (2002) Pathological evaluation of HER2 overexpression: for the treatment of metastatic breast cancers by humanized anti-HER2 monoclonal antibody (trastuzumab). Acta Histochem. Cytochem. 35; 77-81.
20. Valagussa, P. (2001) HER2 status: A statistician's view. Ann. Oncol. 12 (Suppl. 1); S29-S34.